Hepregen Corporation
Biotechnology, 200 Boston Ave, Medford, Massachusetts, 02155, United States, 11-50 Employees
Phone Number: +17*********
Who is HEPREGEN CORPORATION
The mission of Hepregen Corporation is to transform safety assessment and drug development in order to significantly impact patients lives. The company is focused on advancing and commerc...
Read More
-
Headquarters: 200 Boston Ave, Medford, Massachusetts, 02155, United States
-
Date Founded: 2007
-
Employees: 11-50
-
Revenue: $5 Million to $10 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
|
NAICS Code: 541714 |
Show More
Does something look wrong? Fix it. | View contact records from HEPREGEN CORPORATION
Hepregen Corporation Org Chart and Mapping
Email
Phone
Similar Companies to Hepregen Corporation
BioIVT
-
501-1000
-
$ 10 Million to 25 Million
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Hepregen Corporation
Answer: Hepregen Corporation's headquarters are located at 200 Boston Ave, Medford, Massachusetts, 02155, United States
Answer: Hepregen Corporation's phone number is +17*********
Answer: Hepregen Corporation's official website is https://hepregen.com
Answer: Hepregen Corporation's revenue is $5 Million to $10 Million
Answer: Hepregen Corporation's SIC: 8731
Answer: Hepregen Corporation's NAICS: 541714
Answer: Hepregen Corporation has 11-50 employees
Answer: Hepregen Corporation is in Biotechnology
Answer: Hepregen Corporation top competitors include: BioIVT
Answer: Hepregen Corporation contact info: Phone number: +17********* Website: https://hepregen.com
Answer: The mission of Hepregen Corporation is to transform safety assessment and drug development in order to significantly impact patients lives. The company is focused on advancing and commercializing its microliver platform, HepatoPac, into the drug-development pipeline of pharmaceutical and biotechnology companies. We have utilized microtechnology tools adapted from the semiconductor industry to both optimize and miniaturize in multi-well formats an in vitro model of the human liver called HepatoPac, a micro-patterned co-culture (MPCC). Specifically, human hepatocytes are organized into colonies of prescribed, optimized dimensions using microfabrication tools and subsequently surrounded by supportive, non- parenchymal cells. Hepatocytes in HepatoPac retain their in vivo-like morphology, express liver genes, metabolize com- pounds using active Phase I and Phase II drug metabolism enzymes, secrete diverse liverspecific products, and display functional bile canaliculi for up to 4 weeks in vitro Hepregens technology offers the potential to be a more predictive platform for toxicity screening and for drug discovery. It combines sophisticated biological and engineering technologies to create an in vitro liver model which closely mimics many key functions and features of the in vivo human liver. HepatoPac fits into existing work-flows and is amenable to High Content Screening, allowing it to become an integral part of preclinical analysis for DMPK and Safety. In addition, HepatoPac can also be utilized for: efficacy assessment of drugs affecting the liver, biomarker identification, creation of diseased liver models, and utilization with stem cells. Currently, Hepregen is partnered with over 20 pharmaceutical companies using the HepatoPac technology, In 2008, Battelle Ventures spun out Hepregen Corporation from the Massachusetts Institute of Technology (MIT), and led the companys Series A financing.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month